Clinical Nurse Specialist in La Jolla, CA Accepting Medicare
6 Clinical Nurse Specialist nurses found. Showing 1 - 6
 Daniel Pollack, RN, CNS Clinical Nurse Specialist - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 9434 Medical Center Dr, La Jolla, CA 92037 Phone: 858-657-6677 |
 Jennifer Rumsey, APRN, FNP-BC, DNP Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 2850 Moonridge Dr, La Jolla, CA 92037 Phone: 858-880-8640 |
Jennifer Mary Byrne, NP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: Uc Health System Moores Cancer Ctr, 3855health Sciences Drive, #0960, La Jolla, CA 92093 Phone: 858-822-6390 Fax: 858-822-6395 |
Jennifer Harris, CNS Clinical Nurse Specialist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 9300 Campus Point Dr # 3-524, La Jolla, CA 92037 Phone: 858-249-6376 |
Souling Chou, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 9888 Genesee Ave # Lj101, La Jolla, CA 92037 Phone: 858-436-4938 |
Norma Todd, CNS Clinical Nurse Specialist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 9888 Genesee Ave, La Jolla, CA 92037 Phone: 858-626-4123 |
News Archive
UBC researchers lead development of new 'toolbox of MiniPromoters' for gene research and therapy
University of British Columbia researchers have led the development of a new "toolbox of MiniPromoters" for research and future therapies on brain, spinal cord and eye function.
Quinnova Pharmaceuticals raises $17.4 million through Series B financing
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
Britain's youth complacent about HIV/AIDS
New data from surveys across the UK reveal a decline in 12-15 year olds' knowledge about the dangers of HIV/AIDS. Figures from 1995-2001, (see tables), using a sample of 142,281 young people, show a declining trend of youngsters who think that HIV can be passed on by:
NexACT technology demonstrates ability to deliver Taxol subcutaneously
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from the research and development group at its Bio-Quant subsidiary have successfully demonstrated the ability of the NexACT technology to deliver insulin and other large molecule drugs such as Taxol subcutaneously, in a depot-like fashion (or slow release) over a 24 hour period from a single injection.
› Verified 9 days ago